# Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer

> **NCT00062023** · PHASE2 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 12 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** Acetylsalicylic acid (Aspirin)
- **DRUG:** Sulindac
- **DRUG:** Ursodiol
- **OTHER:** Sulindac Placebo

## Key facts

- **NCT ID:** NCT00062023
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-06
- **Primary completion:** 2005-04
- **Final completion:** 2006-05
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Study closed by the NCI.
- **Last updated:** 2012-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00062023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00062023, "Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00062023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*